NK cells and chemokines

Natural Killer Cells

Volumn , Issue , 2010, Pages 203-213

  Gismondi, Angela ^a   Bernardini, Giovanni ^a   Santoni, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957463825     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00015-6     Document Type: Chapter

References (92)

1. al-Aoukaty A., Rolstad B., Maghazachi A.A. Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with G beta gamma after activation of NK cells with chemokines. J Immunol 1999, 162:3249-3255.
2. Allavena P., Bianchi G., Zhou D., van Damme J., Jilek P., Sozzani S., Mantovani A. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 1994, 24:3233-3236.
3. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
4. Barlic J., Sechler J.M., Murphy P.M. IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 2003, 102:3494-3503.
5. Bernardini G., Sciume G., Bosisio D., Morrone S., Sozzani S., Santoni A. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. Blood 2008, 111:3626-3634.
6. Biron C.A. Natural killer cell regulation during viral infection. Biochem Soc Trans 1997, 25:687-690.
7. Bolovan-Fritts C.A., Spector S.A. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood 2008, 111:175-182.
8. Boos M.D., Yokota Y., Eberl G., Kee B.L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 2007, 204:1119-1130.
9. Bouwens L., Remels L., Baekeland M., Van Bossuyt H., Wisse E. Large granular lymphocytes or "pit cells" from rat liver: isolation, ultrastructural characterization and natural killer activity. Eur J Immunol 1987, 17:37-42.
10. Campbell J.J., Qin S., Unutmaz D., Soler D., Murphy K.E., Hodge M.R., Wu L., Butcher E.C. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001, 166:6477-6482.
11. Casilli F., Bianchini A., Gloaguen I., Biordi L., Alesse E., Festuccia C., Cavalieri B., Strippoli R., Cervellera M.N., Di Bitondo R., Ferretti E., Mainiero F., Bizzarri C., Colotta F., Bertini R. Inhibition of interleukin-8 (CXCL8/IL-8)responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochem Pharmacol 2005, 69:385-394.
12. Chuntharapai A., Lee J., Hebert C.A., Kim K.J. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 1994, 153:5682-5688.
13. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science 1995, 268:233-239.
14. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
15. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006, 24:257-286.
16. Dokun A.O., Chu D.T., Yang L., Bendelac A.S., Yokoyama W.M. Analysis of in situ NK cell responses during viral infection. J Immunol 2001, 167:5286-5293.
17. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., Caligiuri M.A. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003, 101:3052-3057.
18. Fogler W.E., Volker K., McCormick K.L., Watanabe M., Ortaldo J.R., Wiltrout R.H. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996, 156:4707-4714.
19. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., Patel Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998, 188:1413-1419.
20. Freud A.G., Becknell B., Roychowdhury S., Mao H.C., Ferketich A.K., Nuovo G.J., Hughes T.L., Marburger T.B., Sung J., Baiocchi R.A., Guimond M., Caligiuri M.A. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005, 22:295-304.
21. Gismondi A., Jacobelli J., Strippoli R., Mainiero F., Soriani A., Cifaldi L., Piccoli M., Frati L., Santoni A. Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J Immunol 2003, 170:3065-3073.
22. Godiska R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., Mantovani A., Gray P.W. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 1997, 185:1595-1604.
23. Gregoire C., Chasson L., Luci C., Tomasello E., Geissmann F., Vivier E., Walzer T. The trafficking of natural killer cells. Immunol Rev 2007, 220:169-182.
24. Gregoire C., Cognet C., Chasson L., Coupet C.A., Dalod M., Reboldi A., Marvel J., Sallusto F., Vivier E., Walzer T. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol 2008, 38:2076-2084.
25. Guo J., Chen T., Wang B., Zhang M., An H., Guo Z., Yu Y., Qin Z., Cao X. Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1. Immunol Lett 2003, 89:1-7.
26. Hanna J., MussaffiH., Steuer G., Hanna S., Deeb M., Blau H., Arnon T.I., Weizman N., Mandelboim O. Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. Blood 2005, 106:3465-3473.
27. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006, 176:1517-1524.
28. Hayakawa Y., Huntington N.D., Nutt S.L., Smyth M.J. Functional subsets of mouse natural killer cells. Immunol Rev 2006, 214:47-55.
29. Hodge D.L., Schill W.B., Wang J.M., Blanca I., Reynolds D.A., Ortaldo J.R., Young H.A. IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J Immunol 2002, 168:6090-6098.
30. Hokeness K.L., Kuziel W.A., Biron C.A., Salazar-Mather T.P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 2005, 174:1549-1556.
31. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
32. Infante-Duarte C., Weber A., Kratzschmar J., Prozorovski T., Pikol S., Hamann I., Bellmann-Strobl J., Aktas O., Dorr J., Wuerfel J., Sturzebecher C.S., Zipp F. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J 2005, 19:1902-1904.
33. Inngjerdingen M., Damaj B., Maghazachi A.A. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001, 97:367-375.
34. Inngjerdingen M., Torgersen K.M., Maghazachi A.A. Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 2002, 99:4318-4325.
35. Kim C.H., Pelus L.M., Appelbaum E., Johanson K., Anzai N., Broxmeyer H.E. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol 1999, 193:226-235.
36. Kim S., Iizuka K., Kang H.S., Dokun A., French A.R., Greco S., Yokoyama W.M. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002, 3:523-528.
37. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16:1-4.
38. Kveberg L., Bryceson Y., Inngjerdingen M., Rolstad B., Maghazachi A.A. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur J Immunol 2002, 32:1856-1864.
39. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
40. Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J.M., Plowman G.D., Rudy B., Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 1995, 376:737-745.
41. Loetscher P., Seitz M., Clark-Lewis I., Baggiolini M., Moser B. Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 1996, 156:322-327.
42. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26:503-517.
43. Maghazachi A.A. Role of the heterotrimeric G proteins in stromal-derived factor-1alpha-induced natural killer cell chemotaxis and calcium mobilization. Biochem Biophys Res Commun 1997, 236:270-274.
44. Maghazachi A.A. G protein-coupled receptors in natural killer cells. J Leukoc Biol 2003, 74:16-24.
45. Maghazachi A.A., Al-Aoukaty A., Schall T.J. CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol 1996, 26:315-319.
46. Mailliard R.B., Alber S.M., Shen H., Watkins S.C., Kirkwood J.M., Herberman R.B., Kalinski P. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 2005, 202:941-943.
47. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 1999, 20:254-257.
48. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
49. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
50. McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002, 14:615-621.
51. Morohashi H., Miyawaki T., Nomura H., Kuno K., Murakami S., Matsushima K., Mukaida N. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 1995, 57:180-187.
52. Morrison B.E., Park S.J., Mooney J.M., Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003, 112:1862-1870.
53. Nieto M., Navarro F., Perez-Villar J.J., del Pozo M.A., Gonzalez-Amaro R., Mellado M., Frade J.M., Martinez A.C., Lopez-Botet M., Sanchez-Madrid F. Roles of chemokines and receptor polarization in NK - target cell interactions. J Immunol 1998, 161:3330-3339.
54. Pallandre, J.R., Krzewski, K., Bedel, R., Ryffel, B., Caignard, A., Rohrlich, P.S., Pivot, X., Tiberghien, P., Zitvogel, L., Strominger, J.L. and Borg, C. (2008). Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation. Blood.
55. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
56. Polentarutti N., Allavena P., Bianchi G., Giardina G., Basile A., Sozzani S., Mantovani A., Introna M. IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol 1997, 158:2689-2694.
57. Rabinowich H., Manciulea M., Herberman R.B., Whiteside T.L. Beta1 integrin-mediated activation of focal adhesion kinase and its association with and Zap-70 in human NK cells. J Immunol 1996, 157:3860-3868.
58. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001, 19:291-330.
59. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
60. Robertson M.J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002, 71:173-183.
61. Robinson L.A., Nataraj C., Thomas D.W., Howell D.N., Griffiths R., Bautch V., Patel, Feng L., Coffman T.M. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 2000, 165:6067-6072.
62. Robinson L.A., Nataraj C., Thomas D.W., Cosby J.M., Griffiths R., Bautch V.L., Patel, Coffman T.M. The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol 2003, 225:122-130.
63. Rosmaraki E.E., Douagi I., Roth C., Colucci F., Cumano A., Di Santo J.P. Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 2001, 31:1900-1909.
64. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
65. Roth C., Rothlin C., Riou S., Raulet D.H., Lemke G. Stromal-cell regulation of natural killer cell differentiation. J Mol Med 2007, 85:1047-1056.
66. Salazar-Mather T.P., Orange J.S., Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998, 187:1-14.
67. Samson S.I., Richard O., Tavian M., Ranson T., Vosshenrich C.A., Colucci F., Buer J., Grosveld F., Godin I., Di Santo J.P. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 2003, 19:701-711.
68. Sancho D., Nieto M., Llano M., Rodriguez-Fernandez J.L., Tejedor R., Avraham S., Cabanas C., Lopez-Botet M., Sanchez-Madrid F. The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol 2000, 149:1249-1262.
69. Saudemont A., Jouy N., Hetuin D., Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005, 105:2428-2435.
70. Shang X., Qiu B., Frait K.A., Hu J.S., Sonstein J., Curtis J.L., Lu B., Gerard C., Chensue S.W. Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol 2000, 157:2055-2063.
71. Silva A., Andrews D.M., Brooks A.G., Smyth M.J., Hayakawa Y. Application of CD27 as a marker for distinguishing human NK cell subsets. Int Immunol 2008, 20:625-630.
72. Soede R.D., Zeelenberg S., Wijnands Y.M., Kamp M., Roos E. Stromal cell-derived factor-1-induced LFA-1 activation during in vivo migration of T cell hybridoma cells requires Gq/11, RhoA, and myosin, as well as Gi and Cdc42. J Immunol 2001, 166:4293-4301.
73. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
74. Taub, Sayers T.J., Carter C.R., Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995, 155:3877-3888.
75. Taub, Ortaldo J.R., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 1996, 59:81-89.
76. Trifilo M.J., Montalto-Morrison C., Stiles L.N., Hurst K.R., Hardison J.L., Manning J.E., Masters P.S., Lane T.E. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J Virol 2004, 78:585-594.
77. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989, 47:187-376.
78. Umehara H., Bloom E.T., Okazaki T., Nagano Y., Yoshie O., Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004, 24:34-40.
79. Vicente-Manzanares M., Sanchez-Madrid F. Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol 2004, 4:110-122.
80. Vosshenrich C.A., Samson-Villeger S.I., Di Santo J.P. Distinguishing features of developing natural killer cells. Curr Opin Immunol 2005, 17:151-158.
81. Vosshenrich C.A., Garcia-Ojeda M.E., Samson-Villeger S.I., Pasqualetto V., Enault L., Richard-Le Goff O., Corcuff E., Guy-Grand D., Rocha B., Cumano A., Rogge L., Ezine S., Di Santo J.P. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006, 7:1217-1224.
82. Wald O., Weiss, Wald H., Shoham H., Bar-Shavit Y., Beider K., Galun E., Weiss L., Flaishon L., Shachar I., Nagler A., Lu B., Gerard C., Gao J.L., Mishani E., Farber J., Peled A. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 2006, 176:4716-4729.
83. Walzer T., Chiossone L., Chaix J., Calver A., Carozzo C., Garrigue-Antar L., Jacques Y., Baratin M., Tomasello E., Vivier E. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007, 8:1337-1344.
84. Walzer T., Jaeger S., Chaix J., Vivier E. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 2007, 19:365-372.
85. Wendel M., Galani I.E., Suri-Payer E., Cerwenka A. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 2008, 68:8437-8445.
86. Widney D.P., Hu Y., Foreman-Wykert A.K., Bui K.C., Nguyen T.T., Lu B., Gerard C., Miller J.F., Smith J.B. CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung. Infect Immun 2005, 73:485-493.
87. Yoneda O., Imai T., Goda S., Inoue H., Yamauchi A., Okazaki T., Imai H., Yoshie O., Bloom E.T., Domae N., Umehara H. Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 2000, 164:4055-4062.
88. Yoneda O., Imai T., Nishimura M., Miyaji M., Mimori T., Okazaki T., Domae N., Fujimoto H., Minami Y., Kono T., Bloom E.T., Umehara H. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Eur J Immunol 2003, 33:53-58.
89. Yu Y.R., Fong A.M., Combadiere C., Gao J.L., Murphy P.M., Patel Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer 2007, 121:316-322.
90. Zabel B.A., Nakae S., Zuniga L., Kim J.Y., Ohyama T., Alt C., Pan J., Suto H., Soler D., Allen S.J., Handel T.M., Song C.H., Galli S.J., Butcher E.C. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008, 205:2207-2220.
91. Zeng X., Moore T.A., Newstead M.W., Hernandez-Alcoceba R., Tsai W.C., Standiford T.J. Intrapulmonary expression of macrophage inflammatory protein 1alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia. Infect Immun 2003, 71:1306-1315.
92. Zeng Y., Huebener N., Fest S., Weixler S., Schroeder U., Gaedicke G., Xiang R., Schramm A., Eggert A., Reisfeld R.A., Lode H.N. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Cancer Res 2007, 67:2331-2338.